Last checked at 26 Apr 2011 16:38
For Immediate Release | 26 April 2011 |
ImmuPharma PLC
Annual Report and Accounts
Notice of Annual General Meeting: 19 May 2011
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2010, has been posted to shareholders.
The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.
The Company's Annual General Meeting will be held on 19 May 2011 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
- Ends -
For further information, please contact:
ImmuPharma PLC:
Dr Robert Zimmer, President & Chief Scientific Officer + 33 389 32 76 50
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080
Richard Warr, Chairman +44 20 7152 4080
Buchanan Communications
Lisa Baderoon
Mark Court +44 20 7466 5000
Panmure, Gordon & Co., NOMAD & Broker
Andrew Burnett
Rakesh Sharma +44 20 7459 3600
Espirito Santo Investment Bank
James Bromhead
Richard Crawley +44 20 7456 9191